Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation

Pristimerin, a quinonemethide triterpenoid, has demonstrated anticancer activity against a number of types of cancer, including breast cancer. However, its mechanism of action remains unclear. The present study investigated the autophagy-induced anticancer efficacy of pristimerin on MDA-MB-231 human...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Younju, Na, Jinuk, Lee, Myung Sun, Cha, Eun Young, Sul, Ji Young, Park, Jun Beom, Lee, Jin Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172393/
https://www.ncbi.nlm.nih.gov/pubmed/30221728
http://dx.doi.org/10.3892/mmr.2018.9488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172393/
https://www.ncbi.nlm.nih.gov/pubmed/30221728
http://dx.doi.org/10.3892/mmr.2018.9488

Ejemplares similares